Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-15-003566)

Filing Details

Accession Number:: 0001387131-15-003566
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-08 14:37:21
Reporting Period:: 2015-12-07

Filing Date:: 2015-12-08
Accepted Time:: 2015-12-08 14:37:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Ohr Pharmaceutical Inc	OHRP	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1630109	Scott Jason Slakter	C/O Ohr Pharmaceuticals Inc. 800 Third Avenue, 11Th Floor New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	100	$4.13	506,246	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	1,200	$4.12	507,446	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	100	$4.10	507,546	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	300	$4.07	507,846	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	300	$4.05	508,146	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	800	$4.02	508,946	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-12-07	200	$4.00	509,146	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015.